252 related articles for article (PubMed ID: 35493091)
1. Plasmalogenic Lipid Analogs as Platelet-Activating Factor Antagonists: A Potential Novel Class of Anti-inflammatory Compounds.
Rong P; Wang JL; Angelova A; Almsherqi ZA; Deng Y
Front Cell Dev Biol; 2022; 10():859421. PubMed ID: 35493091
[TBL] [Abstract][Full Text] [Related]
2. Plasmalogens and platelet-activating factor roles in chronic inflammatory diseases.
Tremblay MÈ; Almsherqi ZA; Deng Y
Biofactors; 2022 Nov; 48(6):1203-1216. PubMed ID: 36370412
[TBL] [Abstract][Full Text] [Related]
3. [Acyl and plasmalogen analogs of platelet activating factor--new lipid cellular bioregulators].
Kulikov VI; Muzia GI
Biokhimiia; 1992 Jun; 57(6):803-16. PubMed ID: 1420585
[TBL] [Abstract][Full Text] [Related]
4. Influence of acyl and plasmalogenic analogs of platelet activating factor on chemotaxis of human leukocytes in vitro and their inflammatory and antiinflammatory activity in vivo.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2002 Nov; 67(11):1248-52. PubMed ID: 12495421
[TBL] [Abstract][Full Text] [Related]
5. Effect of acyl and alkyl analogs of platelet-activating factor on inflammatory signaling.
Marathe GK; Chaithra VH; Ke LY; Chen CH
Prostaglandins Other Lipid Mediat; 2020 Dec; 151():106478. PubMed ID: 32711129
[TBL] [Abstract][Full Text] [Related]
6. Influence of platelet-activating factor, lyso-platelet-activating factor and edelfosine on Langmuir monolayers imitating plasma membranes of cell lines differing in susceptibility to anti-cancer treatment: the effect of plasmalogen level.
Flasiński M; Hąc-Wydro K; Wydro P; Dynarowicz-Łątka P
J R Soc Interface; 2014 Jun; 11(95):20131103. PubMed ID: 24694892
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Platelet-Activating Factor Receptor (PAF-R): Antithrombotic and Anti-Atherosclerotic Nutrients.
Harishkumar R; Hans S; Stanton JE; Grabrucker AM; Lordan R; Zabetakis I
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297097
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 1999 Jun; 64(6):631-5. PubMed ID: 10395976
[TBL] [Abstract][Full Text] [Related]
9. Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells.
Salari H; Dryden P; Howard S; Bittman R
Biochem Cell Biol; 1992 Feb; 70(2):129-35. PubMed ID: 1324692
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of platelet activating factor and related ether lipids: enzymatic pathways, subcellular sites, regulation, and membrane processing.
Snyder F
Prog Clin Biol Res; 1988; 282():57-72. PubMed ID: 3071807
[TBL] [Abstract][Full Text] [Related]
11. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
Tselepis AD; John Chapman M
Atheroscler Suppl; 2002 Dec; 3(4):57-68. PubMed ID: 12573364
[TBL] [Abstract][Full Text] [Related]
12. Common mechanism in endothelin-3 and PAF receptor function for anti-inflammatory responses.
Sato A; Ebina K
Eur J Pharmacol; 2013 Oct; 718(1-3):30-3. PubMed ID: 24055926
[TBL] [Abstract][Full Text] [Related]
13. Plasmalogens, platelet-activating factor and beyond - Ether lipids in signaling and neurodegeneration.
Dorninger F; Forss-Petter S; Wimmer I; Berger J
Neurobiol Dis; 2020 Nov; 145():105061. PubMed ID: 32861763
[TBL] [Abstract][Full Text] [Related]
14. A novel CoA-independent transacetylase produces the ethanolamine plasmalogen and acyl analogs of platelet-activating factor (PAF) with PAF as the acetate donor in HL-60 cells.
Lee TC; Uemura Y; Snyder F
J Biol Chem; 1992 Oct; 267(28):19992-20001. PubMed ID: 1400315
[TBL] [Abstract][Full Text] [Related]
15. Platelet Activating Factor antagonists.
Afroz S; Ara A; Arif M
Pak J Pharm Sci; 1998 Jul; 11(2):5-12. PubMed ID: 16414813
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes.
Stafforini DM; McIntyre TM; Zimmerman GA; Prescott SM
Crit Rev Clin Lab Sci; 2003 Dec; 40(6):643-72. PubMed ID: 14708958
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol as a factor regulating the influence of natural (PAF and lysoPAF) vs synthetic (ED) ether lipids on model lipid membranes.
Flasiński M; Wydro P; Hąc-Wydro K; Dynarowicz-Łątka P
Biochim Biophys Acta; 2013 Nov; 1828(11):2700-8. PubMed ID: 23906729
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Phospholipid Platelet-Activating Factor As a Mediator of Inflammation in Chickens.
Garrido D; Chanteloup NK; Trotereau A; Lion A; Bailleul G; Esnault E; Trapp S; Quéré P; Schouler C; Guabiraba R
Front Vet Sci; 2017; 4():226. PubMed ID: 29326957
[TBL] [Abstract][Full Text] [Related]
19. Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases.
Liu Y; Shields LBE; Gao Z; Wang Y; Zhang YP; Chu T; Zhu Q; Shields CB; Cai J
Mol Neurobiol; 2017 Sep; 54(7):5563-5572. PubMed ID: 27613281
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory and anti-thrombotic properties of lipid bioactives from the entomopathogenic fungus Beauveria bassiana.
Tsoupras A; Kouvelis VN; Pappas KM; Demopoulos CA; Typas MA
Prostaglandins Other Lipid Mediat; 2022 Feb; 158():106606. PubMed ID: 34923152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
